RAS Inhibitor Daraxonrasib Redefines Pancreatic Cancer Treatment After FDA Approval
A phase 3 trial of the pan-RAS inhibitor daraxonrasib doubled median overall survival in previously treated metastatic pancreatic cancer, prompting ...
Tag: FDA approval
Bioelectronic Medicine Summit Charts Neurotechnologies for Patients and Communities
The Sixth Bioelectronic Medicine Summit in New York highlighted bioresorbable implants, gamma-frequency therapy for Alzheimer's disease, vagus nerve advances, and ...
FDA-Approved Antibody-Drug Conjugates Reshape Blood Cancer Treatment
A new review synthesizes the clinical evidence, toxicity profiles and resistance mechanisms behind six FDA-approved antibody-drug conjugates for blood cancers.
Oral GLP-1 therapies reshape obesity treatment, review finds
A new review in Cardiovascular Diabetology describes how FDA-approved oral GLP-1 receptor agonists such as semaglutide and orforglipron are expanding ...
AI Moves From Lab Bench to Epilepsy Clinic, Review Finds
A new review maps how artificial intelligence is transforming epilepsy diagnosis, seizure prediction, personalized treatment and long-term management, while warning ...
Accelerated FDA approval for dostarlimab in biomarker-defined locally advanced rectal cancer
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
FDA-Approved RNA Drugs Show Mostly Mild Side Effects, But Long-Term Safety Data Remain Thin
A new cross-platform review of eighteen FDA-approved RNA therapeutics finds that adverse effects depend more on delivery chemistry and administration ...
FDA Approves Juvmo, a Once-Daily Pill for Parkinson’s Born of Decades-Long D1 Receptor Research
The FDA has approved tavapadon, branded Juvmo, a once-daily D1 dopamine receptor agonist for Parkinson's disease developed from more than ...
New Wave of Psychiatric Drugs Targets Treatment-Resistant Mental Illness
A comprehensive review of drugs approved since 2018 reveals rapid innovation in schizophrenia, bipolar disorder and depression, while anxiety disorders ...
Topical Gene Therapy B-VEC Offers New Hope for Butterfly Skin Disease
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
FDA Approves Atezolizumab for Stage III dMMR Colon Cancer After Landmark ATOMIC Trial
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
FDA Approval of Daraxonrasib Marks Turning Point in Pancreatic Cancer Care
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
Gene Therapy Restores Hearing in Congenital Deafness Trial Milestone
A new review charts the rapid rise of AAV-mediated OTOF gene replacement therapy, from the first human trials to the ...
FDA Grants Approval for Innovative Dual-Action Therapy Targeting Previously Treated Advanced Neuroendocrine Tumors, Supported by Dana-Farber Research
Cabozantinib, an innovative oral tyrosine kinase inhibitor, has recently received approval from the U.S. Food and Drug Administration (FDA) for ...
